Avvio Medical Inc, a clinical-stage medical device company developing advanced kidney stone treatment technologies, has announced that the USA Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to its Enhanced Lithotripsy System (ELS).
Avvio Medical | 30/10/2025 | By Darshana | 264
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy